• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    6.61 0.25(3.93%) Dec 18, 4:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.6
    Mean Recommendation (last week):2.6
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:8.16
    Median Target:8.00
    High Target:14.00
    Low Target:4.50
    No. of Brokers:16

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 26, 2014Maxim GroupUpgradeHoldBuy
    Feb 26, 2014Chardan Capital MarketsDowngradeBuyNeutral
    Jan 24, 2014BMO Capital MarketsUpgradeMarket PerformOutperform
    Dec 23, 2013Chardan Capital MarketsUpgradeNeutralBuy
    Dec 10, 2013StifelUpgradeHoldBuy
    Oct 21, 2013RBC Capital MktsDowngradeOutperformSector Perform
    Oct 14, 2013ArgusDowngradeHoldSell
    Oct 10, 2013BarclaysDowngradeOverweightUnderweight
    Oct 10, 2013Summer Street ResearchDowngradeBuyNeutral
    Oct 10, 2013Chardan Capital MarketsDowngradeBuyNeutral

    More Upgrades & Downgrades for ARIA

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0333
    Buy0333
    Hold0999
    Underperform0000
    Sell0111

    Data provided by Thomson/First Call


    Currency in USD.